Recombinant Human Angiopoietin-like 6 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 8466-AN/CF
Key Product Details
Source
CHO
Accession #
Structure / Form
Disulfide-linked homo-oligomer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Chinese Hamster Ovary cell line, CHO-derived human Angiopoietin-like Protein 6/ANGPTL6 protein
Ala20-Leu470, with an N-terminal c-Myc tag
Ala20-Leu470, with an N-terminal c-Myc tag
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Glu (c-Myc tag)
Predicted Molecular Mass
51 kDa
SDS-PAGE
58-69 kDa and 31-41 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human Angiopoietin‑like Protein 6/ANGPTL6 (Catalog # 8466-AN/CF) is immobilized at 2 µg/mL (100 µL/well), Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera (Catalog # 2078-T4) binds with an ED50 of 30.0-360 ng/mL.
When Recombinant Human Angiopoietin‑like Protein 6/ANGPTL6 (Catalog # 8466-AN/CF) is immobilized at 2 µg/mL (100 µL/well), Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera (Catalog # 2078-T4) binds with an ED50 of 30.0-360 ng/mL.
Scientific Data Images for Recombinant Human Angiopoietin-like 6 Protein, CF
Recombinant Human Angiopoietin‑like Protein 6/ANGPTL6 Binding Activity.
When Recombinant Human Angiopoietin‑like Protein 6/ANGPTL6 (Catalog # 8466-AN/CF) is immobilized at 2 µg/mL (100 µL/well), Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera (2078-T4) binds with an ED50 of 30.0-360 ng/mL.Formulation, Preparation and Storage
8466-AN/CF
| Formulation | Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and CHAPS. |
| Reconstitution | Reconstitute at 100 μg/mL in PBS. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Angiopoietin-like Protein 6/ANGPTL6
References
- Oike, Y. and M. Tabata (2009) Circ. J. 73:2192.
- Kadomatsu, T. et al. (2011) FEBS J. 278:559.
- Kitazawa, M. et al. (2007) J. Pharmacol. Exp. Ther. 323:787.
- Oike, Y. et al. (2005) Nat. Med. 11:400.
- Oike, Y. et al. (2003) Proc. Natl. Acad. Sci. U S A 100:9494.
- Okazaki, H. et al. (2012) J. Dermatol. 39:366.
- Zhang, Y. et al. (2006) Biochem. Biophys. Res. Commun. 347:100.
- Legry, V. et al. (2009) Diabetes. Metab. 35:287.
- Namkung, J. et al. (2011) Metabolism 60:564.
- Stepan, H. et al. (2009) Am. J. Hypertens. 22:314.
- Ebert, T. et al. (2009) Metabolism 58:547.
- Ebert, T. et al. (2014) Horm. Metab. Res. 46:685.
- Akhter, S. et al. (2013) Protein Cell 4:220.
Alternate Names
AGF, Angiopoietin like Protein 6, ANGPTL6, ARP5
Gene Symbol
ANGPTL6
UniProt
Additional Angiopoietin-like Protein 6/ANGPTL6 Products
- All Products for Angiopoietin-like Protein 6/ANGPTL6
- Angiopoietin-like Protein 6/ANGPTL6 cDNA Clones
- Angiopoietin-like Protein 6/ANGPTL6 ELISA Kits
- Angiopoietin-like Protein 6/ANGPTL6 Lysates
- Angiopoietin-like Protein 6/ANGPTL6 Primary Antibodies
- Angiopoietin-like Protein 6/ANGPTL6 Proteins and Enzymes
Product Documents for Recombinant Human Angiopoietin-like 6 Protein, CF
Product Specific Notices for Recombinant Human Angiopoietin-like 6 Protein, CF
For research use only
Loading...
Loading...
Loading...